Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer

Aspirin is a well-known nonsteroidal anti-inflammatory drug (NSAID) that has a recognized role in cancer prevention as well as evidence to support its use as an adjuvant for cancer treatment. Importantly there has been an increasing number of studies contributing to the mechanistic understanding of...

Full description

Bibliographic Details

Main Authors:	Ashley J. Hoskin, Amy K. Holt, Danny N. Legge, Tracey J. Collard, Ann C. Williams, Emma E. Vincent
Format:	Artigo
Language:	Inglês
Published:	Open Exploration Publishing Inc. 2023-08-01
Series:	Exploration of Targeted Anti-tumor Therapy
Subjects:	aspirin cancer metabolism metabolic hallmark colorectal cancer cancer prevention nonsteroidal anti-inflammatory drugs adjuvant for therapy anti-tumour
Online Access:	https://www.explorationpub.com/Journals/etat/Article/1002155
Tags:	Add Tag No Tags, Be the first to tag this record!